This effect remained consistent even after adjusting for factors such as age, gender, CKD stage, urinary albumin creatinine ratio, eGFR, gout, hyperlipidemia, diabetes mellitus, smoking, erythropoietin, ARB or ACEi use, calcium channel blocker, and statin use. The gene discussed is EPO; the disease is hyperlipidemia.